Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Levy

Showing results (1121-1130 of 1,183) with videos related to

Pageof 119
Sort By:
Plos One|August 24, 2021
Using an integrated knowledge translation approach to inform a pilot feasibility randomized controlled trial on peer support for individuals with traumatic brain injury: A qualitative descriptive studyStephanie K C Lau, Dorothy Luong, Shane N Sweet, et al.
Cancer|September 1, 2006
Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysisEric M Horwitz, Lawrence B Levy, Howard D Thames, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesotheliomaRenato Lenzi, Michael Rosenblum, Claire Verschraegen, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|September 10, 2009
Venous thromboembolism--prophylactic and therapeutic practice guidelineB F Jacobson, S Louw, M Mer, et al.
Head & Neck|February 4, 2015
Merkel cell carcinoma of the head and neck: Favorable outcomes with radiotherapyAndrew J Bishop, Adam S Garden, G Brandon Gunn, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Low-dose, fractionated radioimmunotherapy for B-cell malignancies using 131I-Lym-1 antibodyG L DeNardo, S J DeNardo, K R Lamborn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2012
Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancerS X Bian, D A Kuban, L B Levy, et al.
The Journal of Infection|January 29, 2017
Treatment-limiting renal tubulopathy in patients treated with tenofovir disoproxil fumarateL Hamzah, S Jose, J W Booth, et al.
JCI Insight|April 11, 2024
Minnelide suppresses GVHD and enhances survival while maintaining GVT responsesSabrina N Copsel, Vanessa T Garrido, Henry Barreras, et al.
Cancer|July 20, 2016
A phase 1 dose-escalation study of filanesib plus bortezomib and dexamethasone in patients with recurrent/refractory multiple myelomaAjai Chari, Myo Htut, Jeffrey A Zonder, et al.
Pageof 119

Showing results (1121-1130 of 1,183) with videos related to

Sort By:
Pageof 119
Plos One|August 24, 2021
Using an integrated knowledge translation approach to inform a pilot feasibility randomized controlled trial on peer support for individuals with traumatic brain injury: A qualitative descriptive studyStephanie K C Lau, Dorothy Luong, Shane N Sweet, et al.
Cancer|September 1, 2006
Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysisEric M Horwitz, Lawrence B Levy, Howard D Thames, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesotheliomaRenato Lenzi, Michael Rosenblum, Claire Verschraegen, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|September 10, 2009
Venous thromboembolism--prophylactic and therapeutic practice guidelineB F Jacobson, S Louw, M Mer, et al.
Head & Neck|February 4, 2015
Merkel cell carcinoma of the head and neck: Favorable outcomes with radiotherapyAndrew J Bishop, Adam S Garden, G Brandon Gunn, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Low-dose, fractionated radioimmunotherapy for B-cell malignancies using 131I-Lym-1 antibodyG L DeNardo, S J DeNardo, K R Lamborn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2012
Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancerS X Bian, D A Kuban, L B Levy, et al.
The Journal of Infection|January 29, 2017
Treatment-limiting renal tubulopathy in patients treated with tenofovir disoproxil fumarateL Hamzah, S Jose, J W Booth, et al.
JCI Insight|April 11, 2024
Minnelide suppresses GVHD and enhances survival while maintaining GVT responsesSabrina N Copsel, Vanessa T Garrido, Henry Barreras, et al.
Cancer|July 20, 2016
A phase 1 dose-escalation study of filanesib plus bortezomib and dexamethasone in patients with recurrent/refractory multiple myelomaAjai Chari, Myo Htut, Jeffrey A Zonder, et al.
Pageof 119